益丰药房前三季度净利12.25亿元，同比增长10.27%

Core Viewpoint - Yifeng Pharmacy (603939) reported a slight increase in revenue and a notable rise in net profit for the first three quarters of 2025, indicating a stable financial performance despite challenges in store management [1] Financial Performance - The company's revenue for the first three quarters reached 17.286 billion yuan, reflecting a year-on-year growth of 0.39% [1] - The net profit attributable to shareholders was 1.225 billion yuan, showing a year-on-year increase of 10.27% [1] Store Management - During the first nine months, the company opened 137 new stores and closed 440 stores, resulting in a net decrease of 18 stores compared to the end of the previous year [1] - As of the end of the reporting period, the total number of stores was 14,666, which includes 4,097 franchise stores [1] - In the third quarter alone, the company opened 56 new stores, closed 168 stores, and added 77 franchise stores [1]